Parallax Volatility Advisers, L.P. Vir Biotechnology, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $89 - $123	4 New	4 $0
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $1.17 Million - $2.04 Million	-37,690 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $1.16 Million - $2.03 Million	37,503 Added 20055.08%	37,690 $1.58 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $4,770 - $8,112	187 New	187 $5,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.